Edition:
United States

People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

2.60USD
23 Jan 2017
Change (% chg)

$-0.05 (-1.89%)
Prev Close
$2.65
Open
$2.65
Day's High
$2.65
Day's Low
$2.55
Volume
175,413
Avg. Vol
285,578
52-wk High
$4.50
52-wk Low
$2.40

Hoffman, Stephen 

Dr. Stephen J. Hoffman, M.D. Ph.D. is an Independent Director of AcelRx Pharmaceuticals Inc. Dr. Hoffman has been a Senior Advisor to PDL BioPharma, Inc. since February 2014. Prior to that, he served as a managing director at Skyline Ventures, a venture capital firm, from May 2007 until February 2014. From January 2003 to March 2007, Dr. Hoffman was a general partner at TVM Capital, a venture capital firm. Prior to that, he served as President, Chief Executive Officer and a director of Allos Therapeutics, a biopharmaceutical company, from 1994 to 2012; he served as Chairman of the Board from 2002 until its acquisition by Spectrum Pharmaceuticals in 2012. Dr. Hoffman holds a Ph.D. in bio-organic chemistry from Northwestern University and an M.D. from the University of Colorado School of Medicine.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams

--

Richard King

2,030,280

Howard Rosen

--

Timothy Morris

2,106,040

Pamela Palmer

1,661,310

Badri Dasu

1,079,640
As Of  30 Dec 2014